OpenAlex
PricingAboutJobs
Log inGet started
Author

Yali Liu

Institution: Daiichi Sankyo (United States)
Observed institution: Daiichi Sankyo (United States)
ORCID: 0000-0003-2125-3755
Observed ORCID: 0000-0003-2125-3755
OpenAlex ID: A5022448589
Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis
2022 · Guy Jerusalem, Yeon Hee Park, et al. · Cancer Discovery · 118
PDF
Data from Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis
2023 · Guy Jerusalem, Yeon Hee Park, et al.
Supplementary Data from Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis
2023 · Guy Jerusalem, Yeon Hee Park, et al.
Supplementary Data from Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis
2023 · Guy Jerusalem, Yeon Hee Park, et al.
PDF
Supplementary Data from Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis
2023 · Guy Jerusalem, Yeon Hee Park, et al.
PDF
Works count: 5
Citation count: 118
H-index: 1
I10-index: 1
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security